You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

~ Buy the VELPHORO (ferric oxyhydroxide) Drug Profile, 2024 PDF Report in the Report Store ~

VELPHORO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Velphoro patents expire, and when can generic versions of Velphoro launch?

Velphoro is a drug marketed by Vifor Fresenius and is included in one NDA. There are eleven patents protecting this drug.

This drug has one hundred and nineteen patent family members in thirty-five countries.

The generic ingredient in VELPHORO is ferric oxyhydroxide. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ferric oxyhydroxide profile page.

DrugPatentWatch® Generic Entry Outlook for Velphoro

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be July 23, 2030. This may change due to patent challenges or generic licensing.

There have been six patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.

Indicators of Generic Entry

< Available with Subscription >

  Try a Trial

Drug patent expirations by year for VELPHORO
Drug Prices for VELPHORO

See drug prices for VELPHORO

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for VELPHORO
Generic Entry Date for VELPHORO*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET, CHEWABLE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for VELPHORO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Colorado, DenverPhase 4
Prim. Priv. Doz. Dr. Daniel CejkaPhase 2
Vifor Fresenius Medical Care Renal PharmaPhase 2

See all VELPHORO clinical trials

Pharmacology for VELPHORO
Drug ClassPhosphate Binder
Mechanism of ActionPhosphate Chelating Activity

US Patents and Regulatory Information for VELPHORO

VELPHORO is protected by eleven US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of VELPHORO is ⤷  Try a Trial.

This potential generic entry date is based on patent ⤷  Try a Trial.

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting VELPHORO

Pharmaceutical composition, comprising phosphate binder particles
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical composition, comprising phosphate binder particles
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical composition, comprising phosphate binder particles
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Pharmaceutical compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for VELPHORO

When does loss-of-exclusivity occur for VELPHORO?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 9312
Estimated Expiration: ⤷  Try a Trial

Australia

Patent: 08322963
Estimated Expiration: ⤷  Try a Trial

Brazil

Patent: 0820308
Estimated Expiration: ⤷  Try a Trial

Canada

Patent: 00444
Estimated Expiration: ⤷  Try a Trial

China

Patent: 1861146
Estimated Expiration: ⤷  Try a Trial

Patent: 4688702
Estimated Expiration: ⤷  Try a Trial

Patent: 6619710
Estimated Expiration: ⤷  Try a Trial

Patent: 1789820
Estimated Expiration: ⤷  Try a Trial

Patent: 2022796
Estimated Expiration: ⤷  Try a Trial

Patent: 2022821
Estimated Expiration: ⤷  Try a Trial

Patent: 2022822
Estimated Expiration: ⤷  Try a Trial

Colombia

Patent: 80398
Estimated Expiration: ⤷  Try a Trial

Croatia

Patent: 0170034
Estimated Expiration: ⤷  Try a Trial

Patent: 0181837
Estimated Expiration: ⤷  Try a Trial

Patent: 0220318
Estimated Expiration: ⤷  Try a Trial

Patent: 0230588
Estimated Expiration: ⤷  Try a Trial

Cyprus

Patent: 18496
Estimated Expiration: ⤷  Try a Trial

Patent: 21230
Estimated Expiration: ⤷  Try a Trial

Denmark

Patent: 22285
Estimated Expiration: ⤷  Try a Trial

Patent: 43992
Estimated Expiration: ⤷  Try a Trial

Patent: 92069
Estimated Expiration: ⤷  Try a Trial

Patent: 95699
Estimated Expiration: ⤷  Try a Trial

European Patent Office

Patent: 22285
Estimated Expiration: ⤷  Try a Trial

Patent: 43992
Estimated Expiration: ⤷  Try a Trial

Patent: 92069
Estimated Expiration: ⤷  Try a Trial

Patent: 95698
Estimated Expiration: ⤷  Try a Trial

Patent: 95699
Estimated Expiration: ⤷  Try a Trial

Patent: 95700
Estimated Expiration: ⤷  Try a Trial

Finland

Patent: 95699
Estimated Expiration: ⤷  Try a Trial

Guatemala

Patent: 1000144
Estimated Expiration: ⤷  Try a Trial

Hong Kong

Patent: 07298
Estimated Expiration: ⤷  Try a Trial

Hungary

Patent: 31293
Estimated Expiration: ⤷  Try a Trial

Patent: 41429
Estimated Expiration: ⤷  Try a Trial

Israel

Patent: 5726
Estimated Expiration: ⤷  Try a Trial

Patent: 7741
Estimated Expiration: ⤷  Try a Trial

Japan

Patent: 66164
Estimated Expiration: ⤷  Try a Trial

Patent: 61601
Estimated Expiration: ⤷  Try a Trial

Patent: 94260
Estimated Expiration: ⤷  Try a Trial

Patent: 38734
Estimated Expiration: ⤷  Try a Trial

Patent: 64959
Estimated Expiration: ⤷  Try a Trial

Patent: 16055
Estimated Expiration: ⤷  Try a Trial

Patent: 11503148
Estimated Expiration: ⤷  Try a Trial

Patent: 14062120
Estimated Expiration: ⤷  Try a Trial

Patent: 15166359
Estimated Expiration: ⤷  Try a Trial

Patent: 17114873
Estimated Expiration: ⤷  Try a Trial

Patent: 19089805
Estimated Expiration: ⤷  Try a Trial

Patent: 21001192
Estimated Expiration: ⤷  Try a Trial

Patent: 23011873
Estimated Expiration: ⤷  Try a Trial

Lithuania

Patent: 22285
Estimated Expiration: ⤷  Try a Trial

Patent: 43992
Estimated Expiration: ⤷  Try a Trial

Patent: 92069
Estimated Expiration: ⤷  Try a Trial

Malaysia

Patent: 6383
Estimated Expiration: ⤷  Try a Trial

Patent: 3729
Estimated Expiration: ⤷  Try a Trial

Mexico

Patent: 10005346
Estimated Expiration: ⤷  Try a Trial

Morocco

Patent: 898
Estimated Expiration: ⤷  Try a Trial

New Zealand

Patent: 5435
Estimated Expiration: ⤷  Try a Trial

Philippines

Patent: 015500727
Estimated Expiration: ⤷  Try a Trial

Poland

Patent: 22285
Estimated Expiration: ⤷  Try a Trial

Patent: 43992
Estimated Expiration: ⤷  Try a Trial

Patent: 92069
Estimated Expiration: ⤷  Try a Trial

Patent: 95699
Estimated Expiration: ⤷  Try a Trial

Portugal

Patent: 22285
Estimated Expiration: ⤷  Try a Trial

Patent: 43992
Estimated Expiration: ⤷  Try a Trial

Patent: 92069
Estimated Expiration: ⤷  Try a Trial

Patent: 95699
Estimated Expiration: ⤷  Try a Trial

Patent: 95700
Estimated Expiration: ⤷  Try a Trial

Russian Federation

Patent: 93831
Estimated Expiration: ⤷  Try a Trial

Patent: 48760
Estimated Expiration: ⤷  Try a Trial

Patent: 10124424
Estimated Expiration: ⤷  Try a Trial

Patent: 13128356
Estimated Expiration: ⤷  Try a Trial

Saudi Arabia

Patent: 2340044
Estimated Expiration: ⤷  Try a Trial

Singapore

Patent: 8789
Estimated Expiration: ⤷  Try a Trial

Slovenia

Patent: 22285
Estimated Expiration: ⤷  Try a Trial

Patent: 43992
Estimated Expiration: ⤷  Try a Trial

Patent: 92069
Estimated Expiration: ⤷  Try a Trial

Patent: 95699
Estimated Expiration: ⤷  Try a Trial

South Africa

Patent: 1004256
Estimated Expiration: ⤷  Try a Trial

South Korea

Patent: 1438071
Estimated Expiration: ⤷  Try a Trial

Patent: 1590115
Estimated Expiration: ⤷  Try a Trial

Patent: 100126266
Estimated Expiration: ⤷  Try a Trial

Patent: 130030306
Estimated Expiration: ⤷  Try a Trial

Spain

Patent: 12331
Estimated Expiration: ⤷  Try a Trial

Patent: 03158
Estimated Expiration: ⤷  Try a Trial

Patent: 08719
Estimated Expiration: ⤷  Try a Trial

Patent: 50337
Estimated Expiration: ⤷  Try a Trial

Patent: 51457
Estimated Expiration: ⤷  Try a Trial

Taiwan

Patent: 68167
Estimated Expiration: ⤷  Try a Trial

Patent: 92159
Estimated Expiration: ⤷  Try a Trial

Patent: 0938210
Estimated Expiration: ⤷  Try a Trial

Patent: 1509423
Estimated Expiration: ⤷  Try a Trial

Tunisia

Patent: 10000152
Estimated Expiration: ⤷  Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering VELPHORO around the world.

Country Patent Number Title Estimated Expiration
Japan 2021001192 医薬組成物 (PHARMACEUTICAL COMPOSITIONS) ⤷  Try a Trial
Philippines 12015500727 PHARMACEUTICAL COMPOSITIONS ⤷  Try a Trial
Japan 6294260 ⤷  Try a Trial
Portugal 3895699 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for VELPHORO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0868125 PA2015003 Lithuania ⤷  Try a Trial PRODUCT NAME: POLICIKLINES GELEZIES (III) OKSIHIDROKSIDO, SACHAROZES IR KRAKMOLU MISINYS; REGISTRATION NO/DATE: EU/1/14/943/001 - EU/1/14/943/004 20140826
0868125 C300710 Netherlands ⤷  Try a Trial PRODUCT NAME: MENGSEL VAN POLYNUCLEAIRE IJZER (III)-OXYHYDROXIDE, SUCROSE EN ZETMEEL; REGISTRATION NO/DATE: EU/1/14/943 20140826
0868125 C00868125/01 Switzerland ⤷  Try a Trial PRODUCT NAME: FERRIOXYHYDROXIDUM/SACCHARUM/AMYLA; REGISTRATION NO/DATE: SWISSMEDIC 62986 22.01.2015
0868125 SPC/GB14/087 United Kingdom ⤷  Try a Trial PRODUCT NAME: MIXTURE OF POLYNUCLEAR IRON(III)OXYHYDROXIDE, SUCROSE AND STARCHES; REGISTERED: UK EU/1/14/943/001 20140828; UK EU/1/14/943/002 20140828; UK EU/1/14/943/003 20140828; UK EU/1/14/943/004 20140828
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.